GERMANY - Blackstone and Carlyle court Merck
The Blackstone Group and the Carlyle Group are said to be interested in acquiring Merck’s generic business. Both financial investors are believed to be in advanced talks with Indian pharmaceutical companies Ranbaxy and Cipla in order to partner up for a possible buyout.
More on DACH
Toscafund leads €25m round for Elinvar
Existing investors Goldman Sachs Growth, Ampega and Finleap also back the round
EMH sells stake in Native Instruments
SBO to Francisco Partners sees EMH and Native Instruments' management retain a minority stake
InfraVia's Celeste acquires PE-backed VTX Telecom
Exiting their stakes, Iris and Siparex first invested in the telecoms service in 1999 and 2005 respectively
VCs in $50m round for Maps.Me
Navigation and travel app was bought by Parity.com subsidiary Daegu for around €16.65m in 2020
Latest News
LP Profile: IMCO
Managing director Craig Ferguson discusses accelerated deployment activity during the pandemic and plans to scale up the PE allocation by 2025
Elbrus holds first close on $260m for third fund – report
Fund has a target of $600m, which it plans to reach by next year, according to Kommersant
Alta Life Sciences invests in Inbiomotion
Existing investors including Institut Català de Finances also take part in the financing
Korys, FPIM et al. in €12m extended series-B for Remynd
Biotech company initially raised €12m in December 2018